Inogen, Inc. IPO Advisory
Share this IPO Profile:
Smart Search
Company |
Symbol |
Price Range |
Issue Price |
Open |
Shares |
Trade Date |
Inogen, Inc. | INGN - NASDAQ |
$16.00-$18.00 |
$16.00 |
$16.00 | 4.4 million | 2/14/2014 |
J.P. Morgan |
Co-Manager(s): Leerink Swann, William Blair, Stifel |
Health Care |
Filing(s): Filed 2013-11-27
|
For IPO Boutique's "scale of 1 to 5" BUY rating on Inogen, Inc., and our comprehensive analysis, click "Buy Market Research".
Inogen, Inc. Quote & Chart - Click for current quote -
INGN
About Inogen, Inc. (adapted from Inogen, Inc. prospectus):
They are a medical technology company that develops, manufactures and markets innovative portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as "INGN" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.
© 2005 - 2024 IPO Boutique. All Rights Reserved